TITLE

Lipid profile in type 2 diabetic and hypertensive population in Western Algeria

AUTHOR(S)
Gormat, N. Brixi; Benmansour, F.; Hammas, A.
PUB. DATE
August 2011
SOURCE
Annals of Biological Research;2011, Vol. 2 Issue 4, p447
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Dyslipidemia in diabetics are as high blood pressure to take very seriously, given the significant increase in cardiovascular risks they pose to patients. Anomalies of lipoprotein metabolism are of major importance because of the risks atherogenic increased in diabetic patients. [4, 11] In this work we studied the lipid metabolism as a whole and explore some biochemical parameters in diabetic hypertensive population and to compare them to a free sample (non-diabetic nonhypertensive). Our results showed that diabetic hypertensive patients aged 40 to 80 years, have a high percentage of physical inactivity and obesity, increased serum glucose, elevated serum triglycerides hypercholesterolemia, low HDL cholesterol as well as an increase in LDL.
ACCESSION #
73567413

 

Related Articles

  • Association of the HindIII and S447X polymorphisms in LPL gene with hypertension and type 2 diabetes in Mexican families. Muñoz-Barrios, Salvador; Guzmán-Guzmán, Iris Paola; José Francisco; Salgado-Bernabé, Aralia Berenice; Salgado-Goytia, Lorenzo; Parra-Rojas, Isela // Disease Markers;2012, Vol. 33 Issue 6, p313 

    Lipoprotein lipase (LPL) is a key enzyme in lipid metabolism and is associated with obesity, dyslipidemias, hypertension (HTN) and type 2 diabetes mellitus (T2DM). LPL gene polymorphisms can be related with the development of cardiovascular risk factors. The present study was conducted to...

  • CORRELATION BETWEEN GLYCEMIC CONTROL AND LIPID PROFILE IN TYPE 2 DIABETIC PATIENTS: HbA1c AS AN INDIRECT INDICATOR OF DYSLIPIDEMIA. REDDY, A. SREENIVAS; MEERA, S.; EBENEZER, WILLIAM; KUMAR, J. S. // Asian Journal of Pharmaceutical & Clinical Research;2014, Vol. 7 Issue 2, p153 

    Objectives: Dyslipidemia is one of the major risk factor for cardiovascular disease in Type 2 Diabetes mellitus, characterized by elevated Total cholesterol (TC), Triglycerides (TG), Low density lipoprotein (LDL) and decreased High density lipoprotein (HDL). Hemoglobin A1c (HbA1c) is widely used...

  • A Potential Role of Apo B in the Risk Stratification of Type 2 Diabetic Patients with Dyslipidemia. Arathi, C. A.; Prabhudeva, N.; Geetha, J. P. // Indian Journal of Public Health Research & Development;Jul-Dec2012, Vol. 3 Issue 3, p18 

    Background: Dyslipidemia matters in type 2 diabetes and appreciation of the lipid abnormalities in diabetes has changed with time. There are few data on Apo B levels in these patients and consequently there is little information on the frequencies of the various dyslipidemic phenotypes. Methods:...

  • A practical guide to low-density lipoprotein cholesterol treatment targets. Naidoo, Shanil // South African Pharmaceutical Journal;2015, Vol. 82 Issue 9, p13 

    The rate of cardiovascular disease (CVD) in South Africa is rapidly increasing. Elevated low-density lipoprotein (LDL) cholesterol is a major risk factor for CVD. Lowering LDL cholesterol levels to the appropriate treatment targets is strongly associated with a decrease in mortality and improved...

  • Xanthomas: Clinical and pathophysiological relations. Zak, Ales; Zeman, Miroslav; Slaby, Adolf; Vecka, Marek // Biomedical Papers of the Medical Faculty of Palacky University i;Jun2014, Vol. 158 Issue 2, p181 

    Background. Xanthomas are well circumscribed lesions in the connective tissue of the skin, tendons or fasciae that predominantly consist of foam cells; these specific cells are formed from macrophages as a result of an excessive uptake of low density lipoprotein (LDL) particles and their...

  • Study of pattern of dyslipidemia and its correlation with cardiovascular risk factors in patients with proven coronary artery disease. Mahalle, Namita; Garg, M. K.; Naik, Sadanand S.; Kulkarni, Mohan V. // Indian Journal of Endocrinology & Metabolism;Jan/Feb2014, Vol. 18 Issue 1, p48 

    Introduction: Dyslipidemia is a primary, widely established as an independent major risk factor for coronary artery disease (CAD). Asians differs in prevalence of various lipid abnormalities than non-Asians. Hence, this study was conducted with objective to evaluate the lipid abnormalities and...

  • Which One Is More Important, Obesity or Cardio Metabolic Risk Factors? Hosseinpanah, Farhad // International Journal of Endocrinology & Metabolism;2013, Vol. 11 Issue 1, p1 

    The article discusses obesity and cardio metabolic risk factors. It reveals that obesity is linked to dyslipidemia, hypertension and type 2 diabetes. It outlines findings regarding the independent role of obesity in the development of cardiovascular disease (CVD) and all-cause mortality. A...

  • Relationship Between Obesity and Obesity-Related Morbidities Weakens With Aging. Canning, Karissa L.; Brown, Ruth E.; Jamnik, Veronica K.; Kuk, Jennifer L. // Journals of Gerontology Series A: Biological Sciences & Medical ;Jan2014, Vol. 69 Issue 1, p87 

    Background. A weak relationship exists between obesity and mortality risk in older populations, however, the influence of age on the relationship between obesity and morbidity is unclear. The objective of this study was to determine the influence of age on the relationship between obesity and...

  • Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus. Lorber, Daniel // Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy;2014, Vol. 7, p169 

    Type 2 diabetes mellitus (T2DM) is commonly accompanied by other cardiovascular disease (CVD) risk factors, such as hypertension, obesity, and dyslipidemia. Furthermore, CVD is the most common cause of death in people with T2DM. It is therefore of critical importance to minimize the risk of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics